Integrated Genomics Licenses Gene Sequencing Technologies to Genencor

Sep 26, 2001

NEW YORK, Sept. 26 – Integrated Genomics of Chicago has licensed three of its microbial genome sequencing technologies to Genencor, the companies announced Tuesday.

Under the terms of the deal Genencor will have a license to use Integrated Genomics’ genome sequence data for Aspergillus niger , the ERGO bioinformatics tools, and Genome Explorer, which allows scientists to analyze regulatory pathways.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Cancer-Fighting Zombies

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Main menu